-
Medical journals
- Career
Proteasome inhibitors - New Option in the Treatment of Tumor Diseases
Authors: I. Špička; P. Klener
Authors‘ workplace: /. interní klinika 1. LF UK a VFN, Praha
Published in: Čas. Lék. čes. 2004; : 701-704
Category:
Overview
Chemotherapy itself probably will not substantially improve the prognosis of cancer patients in the future. Thereforenew methods are needed - one of the promising option is the direct interference with intracellular metabolism - „thetargeted therapy". Proteasome inhibitors are the example of this new approach and bortezomib is the first agent inthis class, which enters clinical trials. We summarize theoretical background and the first clinical experiences withthis drug
Key words:
proteasome, ubiquitin, bortezomib, multiple myeloma
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Article was published inJournal of Czech Physicians
-
All articles in this issue
- Thromboelastography in Liver Transplantation, a Comparison withConventional Laboratory Tests
- Nuclear Factor kappa B in the Treatment of Inflammatory and Tumor Diseases
- Evaluation ofthe Clinical Effectivity and Toxicity ofthe FDN Regimen (Fludarabin, Mitoxantron, Dexamethason) in Patients with FoUicular Lymphoma
- Monitoring The Important Mycotoxin Biomarkers (ochratoxin A, aflatoxin Mj) in the Czech Population
- Proteasome inhibitors - New Option in the Treatment of Tumor Diseases
- A Severe Čase with Respiratory Insufficiency
- Čase Reports ofPatients with a Marker Chromosome
- ABC of Smoking Cessation. Use ofSimple Advice and Behavioural Support
- Novel Genetic Approaches to the Resolutionof Complex Diseases
- Treatment in the Primary Prevention of Stroke - Still Not Fully Used Option
- Genetic Causes ofthe Thyroid Carcinomas
- Regression of Atherosclerotic Plaques during Treatment with Statins
- Nutrition Genomics
- Journal of Czech Physicians
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Regression of Atherosclerotic Plaques during Treatment with Statins
- Čase Reports ofPatients with a Marker Chromosome
- A Severe Čase with Respiratory Insufficiency
- Evaluation ofthe Clinical Effectivity and Toxicity ofthe FDN Regimen (Fludarabin, Mitoxantron, Dexamethason) in Patients with FoUicular Lymphoma
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career